Dr. Mechoulam’s latest discovery is called EPM301, or cannabidiolic acid methyl ester, also known as CBDa. EPM stands for Endless Potential Molecules, and there are now around 14 patented molecules that are being tested on humans with the US FDAs guidance. The first targets of EPM are psoriasis and inflammatory bowel disease (IBD), which are notoriously difficult to treat.
The years-long push to lock foreign visitors out of the city’s coffeeshops just died in…
When most people think about major hip-hop festivals, Montana rarely enters the conversation. For decades,…
From a black currant sour to an espresso martini riff, here are five THC cocktails…
In the music video for “Ram Pam Pam,” Venezuelan artist Micro TDH put older women…
The new cannabis beverage boom isn’t really about replacing booze. It’s about replacing everything people…
Amber Senter co-founded Supernova Women, the organization that helped shape America’s first cannabis social equity…